Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation

Combination therapy of intravenous immunoglobulin (IVIG) and rituximab showed a good transplant rate in highly sensitized wait-listed patients for deceased donor kidney transplantation (DDKT), but carried the risk of antibody-mediated rejection. The authors investigated the impact of a new combinati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Jeong, Jong Cheol, Jambaldorj, Enkthuya, Kwon, Hyuk Yong, Kim, Myung-Gyu, Im, Hye Jin, Jeon, Hee Jung, In, Ji Won, Han, Miyeun, Koo, Tai Yeon, Chung, Junho, Song, Eun Young, Ahn, Curie, Yang, Jaeseok
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2016
Matèries:
4500
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748896/
https://ncbi.nlm.nih.gov/pubmed/26844479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002635
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars